L

LENZ Therapeutics
D

LENZ

33.780
USD
-0.68
(-1.97%)
مغلق
حجم التداول
15,414
الربح لكل سهم
-3
العائد الربحي
-
P/E
51
حجم السوق
950,777,082
المقالات

العنوان: LENZ Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, theinevitable loss of near vision that impacts the daily lives of nearly all people over 45.